Cullinan Therapeutics Share Price (NASDAQ: CGEM)
$7.68
▲
0.1
(1.32%)
Last updated on
Check the interactive Cullinan Therapeutics Stock chart to analyse performance
Cullinan Therapeutics stock performance
as on August 16, 2025 at 1:29 AM IST
- Today's Low:$7.61Today's High:$7.79
0.91%
Downside
Day's Volatility :2.31%
Upside
1.41%
- 52 Weeks Low:$6.8552 Weeks High:$19.89
10.81%
Downside
52 Weeks Volatility :65.56%
Upside
61.39%
Cullinan Therapeutics Stock Returns
Cullinan Therapeutics Inc Key Stats
Check Cullinan Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Cullinan Therapeutics Stock including INR - Dollar returns
The Cullinan Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cullinan Therapeutics investment value today
Current value as on today
₹47,356
Returns
Returns from Cullinan Therapeutics Stock
Dollar Returns*
₹4,210 (+4.21%)
Indian investors sentiment towards Cullinan Therapeutics Stock
Global Institutional Holdings in Cullinan Therapeutics Inc
Name
Holdings %
MPM Oncology Impact Management LP
12.95%
Bvf Inc
9.73%
BlackRock Inc
7.15%
Deerfield Management Co
6.54%
Vanguard Group Inc
5.15%
Citadel Advisors Llc
4.65%
Analyst Recommendation on Cullinan Therapeutics Stock
Buy
92%Buy
7%Hold
0%Sell
Based on 14 Wall street analysts offering stock ratings for Cullinan Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Cullinan Therapeutics Share Price Target
What analysts predicted
Upside of 256.45%
Target:
$27.38
Current:
$7.68
Cullinan Therapeutics share price target is $27.38, a slight Upside of 256.45% compared to current price of $7.68 as per analysts' prediction.
Cullinan Therapeutics Stock Insights
Price Movement
In the last 1 year, CGEM stock has moved down by -54.2%CGEM vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 121.6%CGEM vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 101.2% return, outperforming this stock by 142.7%
Cullinan Therapeutics Technicals Summary
Sell
Neutral
Buy
Cullinan Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Cullinan Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 1.73% | -17.28% | -56.97% | -42.01% | -74.39% |
 | 7.02% | -14.62% | -51.49% | -7.08% | -6.14% |
 | 9.17% | 35.05% | 67.05% | 80.83% | 38.63% |
 | -14.57% | -15.0% | -19.51% | 33.48% | 44.78% |
 | 40.09% | 79.61% | 63.59% | 100.95% | 220.92% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 9.03 | NA | NA | -3.68 | -0.36 | -0.24 | NA | 8.33 |
| 14.03 | 14.03 | 1.14 | 39.47 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.43 | -0.05 | -0.01 | NA | 34.32 |
| 27.78 | 27.78 | 0.58 | 18.05 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $447.8M | -74.39% | 9.03 | 0.0% |
| Buy | $59.0B | -6.14% | 14.03 | 31.37% |
| NA | $37.5B | 38.63% | NA | -3.89% |
| Buy | $100.1B | 44.78% | 27.78 | 31.86% |
| Buy | $58.0B | 220.92% | NA | -12.96% |
About Cullinan Therapeutics Inc
Key Management of Cullinan Therapeutics Inc
Important FAQs about investing in CGEM Stock from India :
What is Cullinan Therapeutics share price today?
Cullinan Therapeutics share price today is $7.68 as on at the close of the market. Cullinan Therapeutics share today touched a day high of $7.79 and a low of $7.61.
What is the 52 week high and 52 week low for Cullinan Therapeutics share?
Cullinan Therapeutics share touched a 52 week high of $19.89 and a 52 week low of $6.85. Cullinan Therapeutics stock price today, is trending at $7.68, lower by 61.39% versus the 52 week high.
How to invest in Cullinan Therapeutics Stock (CGEM) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Cullinan Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cullinan Therapeutics Shares that will get you 0.1953 shares as per Cullinan Therapeutics share price of $7.68 per share as on August 16, 2025 at 1:29 AM IST.
What is the minimum amount required to buy Cullinan Therapeutics Stock (CGEM) from India?
Indian investors can start investing in Cullinan Therapeutics (CGEM) shares with as little as ₹87.492 or $1 (as of August 17, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Cullinan Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 17, 2025).
Based on Cullinan Therapeutics share’s latest price of $7.68 as on August 16, 2025 at 1:29 AM IST, you will get 1.3021 shares of Cullinan Therapeutics. Learn more about
fractional shares .
What are the returns that Cullinan Therapeutics has given to Indian investors in the last 5 years?
Cullinan Therapeutics stock has given -74.39% share price returns and 17.06% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?
Discover More
Journey Medical Corp$6.92
-4.68%
- T-rex 2x Long Microsoft Daily Target Etf
$35.73
-1.19%
- Heidmar Maritime Holdings Co
$1.55
-0.64%
C&f Financial Corp$68.48
-1.67%
Flexshares Mstar Us Mkt Factors Tilt Etf$233.64
-0.18%
- Global X Purecap Msci En Etf
$24.89
+0.12%
Schwab International Dividend Equity Etf$28.25
+0.46%
Precipio Inc$14.70
-0.07%
First Trust Nasdaq Artificia$50.52
+0.08%